12-16 Patients with stage IIB/C and stage III melanoma, despite radical surgery, have a high risk for relapse within 5 years of their initial treatment. Historically, interferon-alpha-2B has been ...
Primary malignant melanoma is a curable disease, with surgical resection being the gold standard of treatment. For stage III melanoma, which poses a high risk of recurrence, adjuvant checkpoint ...
Moderna’s move into personalised cancer therapy continues to proceed at a rapid pace, with Merck & Co-partnered melanoma vaccine ... patients with high-risk stage 3 or 4 melanoma who were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback